Search General Info
Search Education
Search Partnering Companies
photo
Speaker

Greg Divis

CEO, AVADEL PHARMACEUTICALS
Chesterfield, MO, Missouri, United States
Gregory J. Divis was named CEO in June 2019, after having served as COO and Executive VP and Chief Commercial Officer. Prior to joining Avadel, he served as an Executive in Residence at Linden Capital Partners, a healthcare-focused private equity firm. With over 25 Years of experience in the pharmaceutical industry, Mr. Divis served as President and CEO of Lumara Health, a specialty branded pharmaceutical company focused on women's health. Prior to Lumara, Mr. Divis held general management, sales, marketing and business development roles at Schering Plough and Sanofi-Aventis.
Speaking In
[Available On-Demand]
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is an emerging biopharmaceutical company. The Company’s…